V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 330007587 | 330012428 | 0 | 48.6 | Curative (C) | 2014-02-01 | 2014-02-27 | Carboplatin AUC 6 - 10 | 02 | N | 330011872 | CARBOPLATIN |
| 330007588 | 330004425 | 1.76 | null | Curative (C) | null | 2016-07-20 | Etoposide + Ifosfamide (3 days) | null | null | 330011877 | ETOPOSIDE + IFOSFAMIDE |
| 330007589 | 330004425 | 0 | 0 | Palliative (P) | 2013-11-09 | 2013-12-14 | Carboplatin AUC 2 - 5 | 02 | null | 330011877 | CARBOPLATIN |
| 330007590 | 330004425 | 1.75 | 66.4 | Neo-adjuvant (N) | 2017-12-15 | 2017-12-27 | CISPLATIN + FLUOROURACIL | N | N | 330011877 | CISPLATIN + FLUOROURACIL |
| 330007591 | 330004427 | 1.74 | 69 | Curative (C) | null | 2014-11-16 | PAM x 2 pre-surgery (cycles 1&2) | null | null | 330011902 | MAP |
| 330007592 | 330004428 | 1.69 | 97 | Palliative (P) | 2016-08-26 | 2016-09-27 | Rituximab | N | N | 330011909 | RITUXIMAB |
| 330007593 | 330004429 | 1.7 | 68.2 | Palliative (P) | 2016-02-12 | 2016-02-14 | ETOPOSIDE + IFOSFAMIDE | N | N | 330011916 | ETOPOSIDE + IFOSFAMIDE |
| 330007594 | 330004431 | 1.8 | 74 | Curative (C) | 2014-09-23 | 2015-03-17 | Carboplatin + Etoposide iv&po | 02 | Y | 330011916 | CARBOPLATIN + ETOPOSIDE |
| 330007595 | 330004432 | 0 | 73.8 | Curative (C) | 2013-01-28 | 2013-02-24 | CARBOPLATIN + RT | 2 | N | 330011924 | CARBOPLATIN + RT |
| 330007596 | 330004432 | null | 66.7 | Curative (C) | 2016-05-05 | 2016-11-12 | VAI (Ifos 3g/m2) | 02 | Y | 330011924 | VAI |
| 330007597 | 330004433 | 1.62 | 63.4 | Palliative (P) | 2013-12-21 | 2014-02-03 | Paclitaxel (2 or 3 weekly) | N | Y | 330011931 | PACLITAXEL |
| 330007598 | 330011760 | 1.9 | 80.6 | Palliative (P) | 2018-05-02 | 2018-05-02 | Paclitaxel Priming | N | N | 330011932 | PACLITAXEL |
| 330007599 | 330012429 | 1.8 | null | Curative (C) | 2016-04-17 | 2016-05-10 | EURAMOS TRIAL | N | N | 330011933 | EURAMOS TRIAL |
| 330007600 | 330012429 | 1.67 | 66.5 | Palliative (P) | 2017-01-18 | 2017-03-04 | EURAMOS TRIAL | 2 | null | 330011933 | EURAMOS TRIAL |
| 330007601 | 330013249 | 1.8 | 82.2 | Curative (C) | 2014-03-11 | 2014-03-17 | CARBOPLATIN + RT | N | N | 330011940 | CARBOPLATIN + RT |
| 330007602 | 330013249 | 1.8 | 69.9 | Palliative (P) | 2014-11-06 | 2014-12-14 | Carboplatin + Paclitaxel (3 weekly) | 2 | Y | 330011940 | CARBOPLATIN + PACLITAXEL |
| 330007603 | 330004434 | 1.85 | 80.6 | Curative (C) | 2015-10-23 | 2016-07-02 | ALL UKALL2011 (ProtM-A) C PegAsp | 02 | Y | 330011956 | UKALL2011 |
| 330007604 | 330004437 | 1.06 | 62.25 | Palliative (P) | 2015-04-21 | 2015-12-02 | EURAMOS TRIAL | 02 | N | 330011960 | EURAMOS TRIAL |
| 330007605 | 330004437 | 1.73 | null | Neo-adjuvant (N) | 2013-11-10 | 2013-11-10 | EURAMOS TRIAL | 02 | N | 330011960 | EURAMOS TRIAL |
| 330007606 | 330004440 | 1.64 | 63.4 | Curative (C) | 2013-05-23 | 2014-02-06 | CARBOPLATIN + RT | 02 | N | 330011962 | CARBOPLATIN + RT |
| 330007607 | 330004443 | 1.91 | 78.8 | Curative (C) | 2018-03-27 | 2018-03-28 | VAI (Ifos 3g/m2) | 02 | N | 330011964 | VAI |
| 330007608 | 330010565 | 1.7 | 68.5 | Neo-adjuvant (N) | 2013-02-12 | 2013-04-24 | BENDAMUSTINE + RITUXIMAB | N | N | 330011977 | BENDAMUSTINE + RITUXIMAB |
| 330007609 | 330008423 | 1 | 46.3 | Neo-adjuvant (N) | 2018-04-07 | 2018-04-08 | Bendamustine+Rituximab(Sub Courses) | Y | null | 330011981 | BENDAMUSTINE + RITUXIMAB |
| 330007610 | 330004450 | 1.75 | 83.7 | Palliative (P) | 2015-06-18 | 2016-01-07 | Carbo F | N | N | 330011983 | CARBO + FLUOROURACIL |
| 330007611 | 330004452 | null | 80 | Neo-adjuvant (N) | null | 2017-04-01 | Bendamustine+Rituximab(Sub Courses) | 2 | null | 330011990 | BENDAMUSTINE + RITUXIMAB |
| 330007612 | 330004452 | 1.69 | null | Adjuvant (A) | 2014-10-05 | 2015-05-08 | CARBOPLATIN + ETOPOSIDE | N | N | 330011990 | CARBOPLATIN + ETOPOSIDE |
| 330007613 | 330004452 | 1.81 | 78 | null | 2017-07-15 | 2017-07-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 330011990 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007614 | 330004452 | 1.56 | 60.2 | Curative (C) | 2014-07-22 | 2014-08-16 | Cetuximab + Radiotherapy Maint | 99 | Y | 330011990 | CETUXIMAB + RT |
| 330007615 | 330013041 | 1.69 | 66.6 | Curative (C) | 2016-05-06 | 2016-09-20 | ALL UKALL2011 Maintenance B3 | null | N | 330012004 | UKALL2011 |
| 330007616 | 330004454 | 1.6 | 57 | Curative (C) | 2015-06-25 | 2015-06-27 | EURAMOS TRIAL | N | N | 330012017 | EURAMOS TRIAL |
| 330007617 | 330004455 | 1.85 | 109.9 | Palliative (P) | null | 2015-12-20 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 330012032 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 330007618 | 330004455 | 1.6 | 80.2 | Curative (C) | 2013-02-03 | 2013-03-13 | VAI (Ifos 3g/m2) | N | Y | 330012032 | VAI |
| 330007619 | 330004457 | 1.57 | 65.7 | Neo-adjuvant (N) | 2017-02-07 | 2017-02-26 | Carboplatin+Fluorouracil 4 or 5 day | N | N | 330012037 | CARBO + FLUOROURACIL |
| 330007620 | 330004459 | null | null | Disease modification (D) | null | 2013-08-12 | VAI (Ifos 3g/m2) | null | null | 330012051 | VAI |
| 330007621 | 330004459 | 1.75 | 62 | Palliative (P) | null | 2017-09-27 | Carbo F | null | null | 330012051 | CARBO + FLUOROURACIL |
| 330007622 | 330004459 | 1.73 | 68 | Curative (C) | 2018-01-12 | 2018-02-13 | CARBOPLATIN + RT | 02 | N | 330012051 | CARBOPLATIN + RT |
| 330007625 | 330004461 | 1.6 | 50.7 | Palliative (P) | 2016-12-06 | 2017-01-04 | Carboplatin + Etoposide iv&po | N | Y | 330012071 | CARBOPLATIN + ETOPOSIDE |
| 330007626 | 330004462 | 1.56 | 60.9 | Palliative (P) | 2015-09-09 | 2015-10-06 | CARBO + FLUOROURACIL | null | null | 330012074 | CARBO + FLUOROURACIL |
| 330007627 | 330008432 | null | 104 | Adjuvant (A) | 2018-06-26 | 2018-06-30 | Carboplatin+Fluorouracil 4 or 5 day | N | null | 330012076 | CARBO + FLUOROURACIL |
| 330007628 | 330010572 | null | 59.8 | Palliative (P) | 2017-03-25 | 2017-03-25 | VAI (Ifos 3g/m2) | null | null | 330012077 | VAI |
| 330007631 | 330008434 | 1.65 | null | Curative (C) | 2014-07-10 | 2014-10-15 | Cetuximab + Radiotherapy Maint | N | N | 330012092 | CETUXIMAB + RT |
| 330007632 | 330004466 | null | 72.4 | Palliative (P) | 2015-11-21 | 2016-01-01 | Carboplatin + Paclitaxel (3 weekly) | N | Y | 330012097 | CARBOPLATIN + PACLITAXEL |
| 330007633 | 330004467 | null | 84.2 | Palliative (P) | null | 2015-01-06 | CARBOPLATIN + PACLITAXEL | 2 | null | 330012108 | CARBOPLATIN + PACLITAXEL |
| 330007634 | 330004467 | null | 62.3 | Curative (C) | null | 2015-04-04 | Carboplatin + Etoposide iv&po | N | null | 330012108 | CARBOPLATIN + ETOPOSIDE |
| 330007635 | 330004469 | null | 85.5 | Curative (C) | 2016-08-31 | 2016-09-12 | PACLITAXEL | 02 | null | 330012117 | PACLITAXEL |
| 330007636 | 330004469 | 1.58 | 79.4 | null | 2016-06-11 | 2016-07-15 | Cetuximab + Radiotherapy Maint | N | Y | 330012117 | CETUXIMAB + RT |
| 330007637 | 330004470 | 1.7 | 41.35 | Curative (C) | 2017-12-08 | 2017-12-08 | Carboplatin + Etoposide iv&po | N | Y | 330012129 | CARBOPLATIN + ETOPOSIDE |
| 330007638 | 330008437 | 1.73 | 52.3 | Palliative (P) | 2015-12-28 | 2016-05-20 | CARBOPLATIN + RT | N | N | 330012130 | CARBOPLATIN + RT |
| 330007639 | 330004471 | null | 61.4 | Curative (C) | 2014-04-28 | 2014-06-24 | EURAMOS TRIAL | 2 | null | 330012134 | EURAMOS TRIAL |
| 330007640 | 330004472 | null | 14.4 | null | 2016-10-06 | 2017-01-01 | Carboplatin + Paclitaxel (3 weekly) | 02 | N | 330012134 | CARBOPLATIN + PACLITAXEL |